Aim and Scope
European Journal of Therapeutics (Eur J Ther) is an official, double-anonymous, peer-reviewed, open access journal by the Gaziantep University Faculty of Medicine.
The European Journal of Therapeutics is an international, peer-reviewed journal that addresses current developments and new treatment approaches for researchers working in basic and clinical medical sciences, dentistry, and other health sciences. The journal covers all branches of medicine and publishes original scientific articles, evaluating submissions based on their scientific significance, novelty, and relevance. All articles undergo a double-blind peer review process. The aim of the journal is to support the dissemination of high-quality research and contribute to the advancement of knowledge in the field of health sciences. The target audience includes researchers, physicians, and healthcare professionals who are interested or involved in all medical disciplines.
European Journal of Therapeutics is published online and in print. The journal publishes content in English.
e-ISSN: 2564-7040
ISSN: 2564-7784
Title abbreviation: Eur J Ther
Published in the year: 1990
European Journal of Therapeutics is an open access journal. All content is available for use and distribution without delay, with no embargo period or requirement for users to register to read content (https://eurjther.com/index.php/home/issue/archive). No charge for the print version of the journal. The European Journal of Therapeutics offers authors a completely free publishing service; no fees are charged for article submission, article processing, or final publication of their work. All submissions undergo a double-anonymous peer review by at least two independent experts to ensure scientific quality and relevance. The process follows COPE's ethical guidelines, with editorial decisions based on reviewer recommendations.
The European Journal of Therapeutics is published six issues a year (February, April, June, August, October, and December). Published content is preserved long-term using the PKP Preservation Network (PKP PN), LOCKSS, CLOCKSS, and GAÜN DSpace (Gaziantep University) to ensure permanent accessibility. Authors maintain complete ownership of all patent and other proprietary rights, including copyright, of their published articles. All articles are published under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0), allowing non-commercial use and distribution with proper attribution.
The journal's target audience comprises researchers, physicians, and healthcare professionals actively engaged in or deeply interested in all disciplines across the broad spectrum of medical sciences.
The European Journal of Therapeutics accepts articles of the following types for publication: original research, review articles, case reports, letters to the Editor, editorials (only Editors use), special editorial (only Editors use), reply by authors, in memory of (invited by EIC only) and book review (invited by EIC only). All submissions must significantly advance therapeutic knowledge.
European Journal of Therapeutics implements an "Early View" publication model. Under this policy, manuscripts that have completed the peer review process, received editorial acceptance, and undergone final typesetting are published online with a Digital Object Identifier (DOI) before being assigned to a specific volume and issue. For details, please refer to the Early View Publication Policy page.
Last Revised on August 2025
